Tapentadol Versus Oxycodone - a Mechanism-based Treatment Approach in Neuropathic Pain
Launched by UNIVERSITY HOSPITAL SCHLESWIG-HOLSTEIN · Oct 20, 2011
Trial Information
Current as of May 01, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • thermal or mechanical hyperalgesia
- • chronic neuropathic pain (NRS =\> 6)
- Exclusion Criteria:
- • non-specific
About University Hospital Schleswig Holstein
University Hospital Schleswig-Holstein (UKSH) is a leading academic medical center in Germany, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution, UKSH integrates cutting-edge medical research with comprehensive patient care, fostering an environment that promotes the development of novel therapeutic strategies. With a multidisciplinary approach and a strong emphasis on collaboration, UKSH is dedicated to enhancing clinical outcomes and contributing to the global medical community through rigorous scientific inquiry and the translation of research findings into practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kiel, Schleswig Holstein, Germany
Patients applied
Trial Officials
Ralf Baron, Prof. Dr.
Principal Investigator
Head of Unit of Neuropathic Pain Research and Therapy, Department of Neurology, University Clinic Kiel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials